Birchview Capital as of March 31, 2024
Portfolio Holdings for Birchview Capital
Birchview Capital holds 59 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 31.2 | $38M | 704k | 54.23 | |
| Neurocrine Biosciences (NBIX) | 8.7 | $11M | 77k | 137.92 | |
| Biodesix (BDSX) | 6.1 | $7.4M | 5.2M | 1.43 | |
| Aziyo Biologics (ELUT) | 4.3 | $5.2M | 1.7M | 3.15 | |
| ACADIA Pharmaceuticals (ACAD) | 3.8 | $4.6M | 250k | 18.49 | |
| Encana Corporation (OVV) | 3.6 | $4.4M | 84k | 51.90 | |
| Prothena Corp SHS (PRTA) | 3.4 | $4.2M | 170k | 24.77 | |
| Quidel Corporation | 2.6 | $3.1M | 65k | 47.94 | |
| Silk Road Medical Inc Common | 2.4 | $2.9M | 158k | 18.32 | |
| Stoke Therapeutics (STOK) | 2.3 | $2.8M | 210k | 13.50 | |
| Phreesia (PHR) | 2.2 | $2.7M | 115k | 23.93 | |
| United Therapeutics Corporation (UTHR) | 2.1 | $2.5M | 11k | 229.72 | |
| Masimo Corporation (MASI) | 1.8 | $2.2M | 15k | 146.85 | |
| Foghorn Therapeutics (FHTX) | 1.8 | $2.2M | 321k | 6.71 | |
| Harrow Health (HROW) | 1.6 | $2.0M | 150k | 13.23 | |
| Docgo (DCGO) | 1.5 | $1.9M | 460k | 4.04 | |
| Inhibrx | 1.4 | $1.7M | 48k | 34.96 | |
| Equitrans Midstream Corp (ETRN) | 1.4 | $1.7M | 133k | 12.49 | |
| Axogen (AXGN) | 1.1 | $1.4M | 173k | 8.07 | |
| Protagonist Therapeutics (PTGX) | 1.1 | $1.4M | 48k | 28.93 | |
| Alkermes SHS (ALKS) | 1.1 | $1.4M | 50k | 27.07 | |
| Corcept Therapeutics Incorporated (CORT) | 1.0 | $1.3M | 50k | 25.19 | |
| Alphatec Holdings (ATEC) | 1.0 | $1.2M | 88k | 13.79 | |
| 10x Genomics Cl A Com (TXG) | 0.9 | $1.1M | 30k | 37.53 | |
| Apellis Pharmaceuticals (APLS) | 0.9 | $1.1M | 18k | 58.78 | |
| Pioneer Natural Resources | 0.8 | $998k | 3.8k | 262.50 | |
| Travere Therapeutics (TVTX) | 0.8 | $941k | 122k | 7.71 | |
| Progyny (PGNY) | 0.7 | $839k | 22k | 38.15 | |
| Karyopharm Therapeutics (KPTI) | 0.6 | $709k | 470k | 1.51 | |
| Cytokinetics (CYTK) | 0.6 | $701k | 10k | 70.11 | |
| Coherus Biosciences (CHRS) | 0.5 | $645k | 270k | 2.39 | |
| Arvinas Ord (ARVN) | 0.5 | $619k | 15k | 41.28 | |
| Kiniksa Pharmaceuticals | 0.5 | $592k | 30k | 19.73 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $546k | 46k | 11.86 | |
| Springworks Therapeutics (SWTX) | 0.4 | $492k | 10k | 49.22 | |
| Keros Therapeutics (KROS) | 0.4 | $463k | 7.0k | 66.20 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $431k | 10k | 43.05 | |
| Cullinan Oncology (CGEM) | 0.3 | $428k | 25k | 17.04 | |
| Bluebird Bio (BLUE) | 0.3 | $411k | 321k | 1.28 | |
| Halozyme Therapeutics (HALO) | 0.3 | $407k | 10k | 40.68 | |
| Biohaven Pharmaceutical Holding | 0.3 | $403k | 7.4k | 54.69 | |
| G1 Therapeutics | 0.3 | $346k | 80k | 4.32 | |
| Amicus Therapeutics (FOLD) | 0.3 | $330k | 28k | 11.78 | |
| Sarepta Therapeutics (SRPT) | 0.3 | $324k | 2.5k | 129.46 | |
| Accelr8 Technology | 0.3 | $322k | 325k | 0.99 | |
| Axsome Therapeutics (AXSM) | 0.3 | $319k | 4.0k | 79.80 | |
| Castle Biosciences (CSTL) | 0.3 | $310k | 14k | 22.15 | |
| Xencor (XNCR) | 0.2 | $272k | 12k | 22.13 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.2 | $252k | 16k | 15.76 | |
| Wave Life Sciences SHS (WVE) | 0.2 | $247k | 40k | 6.17 | |
| Cabaletta Bio (CABA) | 0.1 | $171k | 10k | 17.06 | |
| Gossamer Bio (GOSS) | 0.1 | $163k | 138k | 1.18 | |
| Ventyx Biosciences (VTYX) | 0.1 | $158k | 29k | 5.50 | |
| Liquidia Technologies (LQDA) | 0.1 | $148k | 10k | 14.75 | |
| 2seventy Bio (TSVT) | 0.1 | $106k | 20k | 5.35 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $102k | 20k | 5.08 | |
| Inflarx Nv (IFRX) | 0.1 | $77k | 50k | 1.54 | |
| Cero Therapeutics Holdings Class A Com (CERO) | 0.0 | $40k | 13k | 3.07 | |
| Yield10 Bioscience | 0.0 | $7.1k | 19k | 0.38 |
